2009—2011年武汉地区24家医院抗组胺药物应用分析  

Utilization of antihistamine agents in 24 hospitals of Wuhan city during 2009-2011

作　　者：贡雪芃[1] 杨红斌[1] 杜光[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院,湖北武汉430030

出　　处：《中国医院药学杂志》2014年第3期235-238,共4页Chinese Journal of Hospital Pharmacy

摘　　要：目的:了解武汉地区抗组胺药物临床应用情况及用药趋势。方法:采用用药金额、用药频率、限定日费用等指标,对武汉地区24家医院2009-2011年抗组胺药物使用数据进行统计、分析。结果:2009-2011年武汉地区抗组胺药物用药量呈明显上升趋势。3年中用药金额排序前3位的是依匹斯汀、氯雷他定和依巴斯汀。用药频度排名前3位的药物是西替利嗪、左西替利嗪和依巴斯汀。结论:武汉地区抗组胺药物应用基本合理。第2代抗组胺药物占据市场主导地位。第3代抗组胺药物市场份额逐年增加。OBJECtiVE To investigate the status quo and tendency of the utilization of antihistamine agents. METHODS The consumption sum, DDDs, defined daily cost, and order ratio of antihistamine agents were collected and analyzed in 24 hospitals of Wuhan city during 2009-2011. RESULTS The consumption of antihistamine agents increased significantly during 2009 -2011. Epinastine, loratadine, ebastine were the top 3 drugs in terms of consumption sum. Cetirizine, levocetirizine, and ebastine ranked the top 3 according to DDDs. CONCLUSION The utilization of antihistamine agents in Wuhan city was rational on the whole. The second generation antihistamine drugs were the first choice in clinical medicine. The sales proportion of third generation antihistamine drugs increased year by year.

关 键 词：抗组胺药物 用药金额 用药频度 限定日费用 

分 类 号：R969.3[医药卫生—药理学]